Cardiac Amyloidosis as a Potential Risk Factor for Transapical Transcatheter Aortic Valve Implantation

Authors:
Publisher website
Google Scholar
Abstract
Transcatheter aortic valve implantation via transarterial or transapical access is an alternative therapy to treat high-risk patients with severe symptomatic aortic stenosis. Despite growing experience, procedural complications may still occur. We herein report an 86-year-old female patient with fatal left ventricular rupture after transapical transcatheter aortic valve implantation with an Edwards Sapien prosthesis due to severe cardiac amyloidosis.

This publication has 3 references indexed in Scilit: